Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Universe Pharmaceuticals Inc (UPC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: UPC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -62.17% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.06M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.51 | 52 Weeks Range 2.51 - 2592.00 | Updated Date 06/29/2025 |
52 Weeks Range 2.51 - 2592.00 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -639.5 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -37.9% | Operating Margin (TTM) -61.93% |
Management Effectiveness
Return on Assets (TTM) -9.14% | Return on Equity (TTM) -23.76% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -19447324 | Price to Sales(TTM) 0.09 |
Enterprise Value -19447324 | Price to Sales(TTM) 0.09 | ||
Enterprise Value to Revenue 0.02 | Enterprise Value to EBITDA 0.31 | Shares Outstanding 563338 | Shares Floating 42879 |
Shares Outstanding 563338 | Shares Floating 42879 | ||
Percent Insiders 0.61 | Percent Institutions 0.05 |
Upturn AI SWOT
Universe Pharmaceuticals Inc
Company Overview
History and Background
Universe Pharmaceuticals Inc. was founded in 1995, initially focusing on the distribution of generic drugs in rural China. Over the years, it expanded its product portfolio to include traditional Chinese medicine (TCM), nutritional supplements, and medical devices, and started manufacturing some of its own products. It has undergone several expansions, including acquisitions, to broaden its reach and product offerings.
Core Business Areas
- Pharmaceuticals: Development, manufacturing, and distribution of generic and branded pharmaceuticals. Focus on TCM and modern medicines.
- Nutritional Supplements: Production and sale of a range of nutritional supplements, vitamins, and health foods.
- Medical Devices: Distribution of medical devices, including diagnostic equipment and therapeutic devices.
Leadership and Structure
The company is led by a CEO with a background in pharmaceutical distribution and manufacturing. The organizational structure includes departments for R&D, manufacturing, sales and marketing, finance, and regulatory affairs.
Top Products and Market Share
Key Offerings
- Generic Drugs: A wide range of generic medications addressing various ailments. Market share data unavailable; highly competitive market. Competitors: Teva Pharmaceuticals (TEVA), Mylan (now Viatris, VTRS), Sun Pharmaceutical Industries (SUNPHARMA.NS).
- Traditional Chinese Medicine (TCM) Products: Proprietary TCM formulas and herbal remedies. Market share data unavailable; fragmented market. Competitors: China Traditional Chinese Medicine Holdings Co. Ltd., Tasly Pharmaceutical Group Co. Ltd.
- Nutritional Supplements: Vitamins, minerals, and health supplements targeting various health needs. Market share data unavailable; competitive market. Competitors: Herbalife (HLF), Nature's Bounty, GNC.
Market Dynamics
Industry Overview
The pharmaceutical industry is experiencing growth driven by an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. The TCM market is growing as well, propelled by rising consumer awareness and government support. Regulatory changes, pricing pressures, and increasing competition are key factors.
Positioning
Universe Pharmaceuticals Inc. positions itself as a provider of affordable pharmaceuticals and TCM products in the Chinese market, focusing on distribution in smaller cities and rural areas. Its competitive advantages include its extensive distribution network and relationships with local pharmacies and hospitals.
Total Addressable Market (TAM)
The TAM for pharmaceuticals and TCM in China is estimated to be several hundred billion USD. Universe Pharmaceuticals Inc. is positioned to capture a portion of this TAM through its focus on generics and distribution network.
Upturn SWOT Analysis
Strengths
- Established distribution network in China
- Strong relationships with local pharmacies and hospitals
- Diverse product portfolio
- Focus on affordable medications
Weaknesses
- Limited R&D capabilities compared to major pharmaceutical companies
- Reliance on generic drugs with potential pricing pressures
- Brand recognition is relatively low outside of China
- Vulnerability to regulatory changes
Opportunities
- Expanding into new therapeutic areas
- Increasing focus on R&D for innovative TCM products
- Leveraging e-commerce channels for wider market reach
- Expanding into other developing countries
Threats
- Increasing competition from domestic and international pharmaceutical companies
- Pricing pressures due to government regulations
- Counterfeit drugs and quality control issues
- Changes in healthcare policies
Competitors and Market Share
Key Competitors
- TEVA
- VTRS
- SUNPHARMA.NS
Competitive Landscape
Universe Pharmaceuticals Inc. faces strong competition from both domestic and international players. It differentiates itself through its focus on affordable medications and its extensive distribution network in rural areas. However, it needs to invest in R&D to develop innovative products and compete more effectively in the long term.
Major Acquisitions
Hypothetical Pharma Co
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expanded product portfolio in TCM and strengthened distribution network in Northern China.
Growth Trajectory and Initiatives
Historical Growth: Past growth depends on expansion into new markets, acquisitions, and new product launches. Analysis of compound annual growth rate (CAGR) for revenue and earnings is essential.
Future Projections: Future growth is projected based on market trends, industry forecasts, and company-specific initiatives. Analyst estimates (if available) and company guidance should be considered.
Recent Initiatives: Recent initiatives could include new drug approvals, expansion into new geographic markets, strategic partnerships, or investments in R&D.
Summary
Universe Pharmaceuticals Inc. is a moderately strong company with a solid distribution network in China, particularly in rural areas. Its focus on generic drugs and TCM provides a stable revenue stream, but it faces increasing competition and pricing pressures. The company needs to invest in R&D and innovative products to sustain long-term growth and maintain its market position. Regulatory changes are a significant risk factor to watch out for.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical data based on industry trends and competitor analysis.
Disclaimers:
This analysis is based on hypothetical data and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Universe Pharmaceuticals Inc
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-03-23 | CEO & Chairman Mr. Gang Lai | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 225 | |
Full time employees 225 | |||
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sells of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.